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Abstract
Background: In secondary care the Wells clinical decision rule (CDR) combined with a quantitative D-dimer test
can exclude pulmonary embolism (PE) safely. The introduction of point-of-care (POC) D-dimer tests facilitates a
similar diagnostic strategy in primary care.
We estimated failure-rate and efficiency of a diagnostic strategy using the Wells-CDR combined with a POC-
D-dimer test for excluding PE in primary care.
We considered ruling out PE safe if the failure rate was <2% with a maximum upper confidence limit of 2.7%.
Methods: We performed a scenario-analysis on data of 2701 outpatients suspected of PE. We used test
characteristics of two qualitative POC-D-dimer tests, as derived from a meta-analysis and combined these with the
Wells-CDR-score.
Results: In scenario 1 (SimpliRed-D-dimer sensitivity 85%, specificity 74%) PE was excluded safely in 23.8% of
patients but only by lowering the cut-off value of the Wells rule to <2. (failure rate: 1.4%, 95% CI 0.6-2.6%)
In scenario 2 (Simplify-D-dimer sensitivity 87%, specificity 62%) PE was excluded safely in 12.4% of patients pro-
vided that the Wells-cut-off value was set at 0. (failure rate: 0.9%, 95% CI 0.2-2.6%)
Conclusion: Theoretically a diagnostic strategy using the Wells-CDR combined with a qualitative POC-D-dimer test
can be used safely to exclude PE in primary care albeit with only moderate efficiency.
Background
Pulmonary embolism (PE) has an estimated annual inci-
dence of 23 cases per 100.000 persons [1]. Because PE is
potentially life-threatening, immediate diagnosis and
management is essential. As primary care physicians
lack accurate diagnostic tools, all patients have to be
referred, often with all due speed to secondary care in
case PE is suspected. However in 75-95% of these
referred patients PE subsequently is excluded [2-4]. Sev-
eral management-studies in secondary care have demon-
strated that PE can be excluded safely in patients with a
low (<2) or unlikely (≤4) clinical probability according
to the clinical decision rule (CDR) as developed by
Wells et al.(Table 1), combined with a normal D-dimer
test result (both quantitative and qualitative D-dimer
tests) [5-8]. The introduction of easy-to-use rapid point-
of-care (POC) D-dimer tests makes it possible to
exclude PE safely in the primary care setting, using a
diagnostic work-up similar to that in secondary care
thereby avoiding unnecessary referrals.
Qualitative POC D-dimer tests do not need additional
equipment or calibration, are ready to use, cheap, utilize
capillary or venous blood and can be done in-and out-
side the clinic. They can be interpreted within 10 min-
utes as either positive or negative which make the tests
suitable for use in primary care. Questions have been
raised however about the sensitivity of the tests ranging
from 80-100% in different studies [7,9-13].
To our knowledge a management-study with a diag-
nostic strategy using a CDR in combination with POC-
D-dimer test for excluding PE has not been performed
in primary care although this approach was successfully
used in the setting of suspected deep vein thrombosis
(DVT) [14]. We performed a scenario-analysis to
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strategy in patients referred by their primary care physi-
cian for suspected PE. Because exclusion of PE is based
on the probability score of the Wells rule combined
with the result of a qualitative D-dimer test we aimed to
calculate a safety-threshold by varying the cut-off value
of the Wells-rule.
Methods
For the present analysis we used data from a large pro-
spective management study, the Christopher-study,
including 3306 consecutive in-and outpatients, sus-
pected of pulmonary embolism [8]. This study was per-
formed in secondary care in the Netherlands between
November 2002 and September 2004. It evaluated the
safety of excluding PE by a sequential diagnostic work-
up consisting of the dichotomous Wells CDR (cut-off ≤
4), a quantitative D-dimer test and helical computer
tomography (CT). Patients with a CDR indicating PE
unlikely underwent D-dimer testing. Either the Vidas
ELISA D-dimer test or the Tinaquant D-dimer test was
used (cut-off ≤500 μg/l, combined sensitivity 97.8% and
specificity 56.9%) and when normal, the diagnosis of PE
was considered excluded. All other patients underwent
helical CT. All patients were followed up for a period of
3 months to document the occurrence of subsequent
symptomatic venous thrombo-embolism (VTE).
We used test characteristics of two qualitative POC D-
dimer tests from a meta-analysis on the diagnostic accu-
racy of POC-D-dimer tests for excluding VTE [15].
1. SimpliRed D-dimer (sensitivity 85%, specificity
74%) is a semi qualitative test performed by mixing
capillary or venous blood with a drop of test reagent
in the test well. A positive result is defined as any
visible agglutination within two minutes.
2. Simplify D-dimer (sensitivity 87%, specificity 62%)
is a qualitative test and is performed by mixing 35 μl
of capillary or venous blood with two drops of test
reagent. A positive result is indicated by a visible
pink-purple coloured line that forms at the test
zone. The test can be read within 10 minutes.
To mimic a primary care setting we excluded all inpa-
tients from the original cohort for the present analysis.
As would be the case in primary care all patients with
Wells CDR >4 needed imaging regardless of the
D-dimer test result. Hence in these patients no addi-
tional D-dimer testing was performed.
Using the original Christopher-study data, we divided
the remaining patients into groups according to their
individual Wells-CDR scoresw i t hd i f f e r e n tc u t - o f f
values (Table 2). Within each group PE was excluded in
patients with the combination of a Wells-CDR below
the cut-off value and a negative D-dimer test result.
Combining the prevalence of PE in each group with the
sensitivity and specificity of the D-dimer test we calcu-
lated the theoretical failure-rate and the efficiency of the
combined strategy in each clinical probability group.
Efficiency was defined as the proportion of all study
patients, in whom PE was excluded (and thus would not
need referral) based on a Wells-CDR below various cut-
off values and a negative D-dimer test.
The failure rate was defined as the proportion of
patients in whom PE was excluded based on a Wells-
CDR below various cut-off values and a negative
D-dimer test, with symptomatic and proven VTE during
3 months follow-up.
We considered ruling out PE safe if the failure rate
was <2% with a maximum upper confidence limit of
2.7%, being the upper confidence limit of the three-
month thrombo-embolic rate of patients suspected of
PE but with a normal pulmonary angiography [16].
The 95% confidence intervals (CI) were calculated
using Confidence Interval Analysis (CIA, version 1.0;
Gardner MJ).
Results
Of the total study population of 3306 in-and outpati-
ents, 2701 were outpatients a n di n c l u d e di nt h i sa n a l y -
sis. The prevalence of PE in the group of outpatients
was 20.2%. (including the 3-months follow-up period).
T h ep r e v a l e n c eo fP Ea m o n gpatients with an unlikely
clinical probability decreased with a decreasing CDR-
cut-off value, ranging from 12.0% in patients with a
Wells score ≤ 4 to 4.3% in patients with a Wells score
of 0.
Table 1 Wells clinical decision rule
Variable Points
Clinical signs and symptoms of DVT
(minimum of leg swelling and pain with palpation of the deep
veins)
3.0
Alternative diagnosis less likely than PE 3.0
Heart rate > 100/min 1.5
Immobilization (>3 days) or surgery in the previous 4 weeks 1.5
Previous PE or DVT 1.5
Haemoptysis 1.0
Malignancy
(receiving treatment, treated in the last 6 months or palliative)
1.0
Clinical probability of PE:
Unlikely ≤4 points
Likely >4 points
Low <2 points
Intermediate 2-6 points
High >6 points
Abbreviations: DVT, deep vein thrombosis; PE, pulmonary embolism
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different cut-off values of the Wells-CDR in combina-
tion with the sensitivity and specificity of the D-dimer
test. In the last column results of the outpatients
obtained from the Christopher-study are depicted for
comparison. In the Christopher-study PE could be
excluded safely with a Wells-CDR cut-off value of ≤ 4i n
35.0% of the patients.
However the failure rate of 2.7% is exceeded in both
qualitative POC D-dimer tests when combined with a
Wells-CDR cut off value of ≤ 4. To meet the safety cri-
teria (failure rate <2%, upper 95% CI <2.7%) the Sim-
pliRed D-dimer test had to be combined with a Wells
CDR-cut off value <2 and the Simplify D-dimer test
with a Wells CDR-cut off value of 0. Using this strategy,
the proportion of patients in whom PE might be
excluded safely decreased to 23.8% with the SimpliRed
D-dimer test and 12.4% with the Simplify D-dimer test.
The dramatic loss in efficiency when using a lower
Wells-CDR cut off is demonstrated in figure 1.
Discussion
The current scenario-analysis determined the theoretical
failure-rate and efficiency of a diagnostic strategy using
the Wells CDR at different cut-off values combined with
a qualitative POC D-dimer test for excluding PE in pri-
mary care. Excluding PE safely in primary care with a
CDR and a point-of-care D-dimer test seems feasible.
However, the strategy appeared to be safe only when
the cut-off value of the Wells-CDR was lowered to <2
using the SimpliRed and 0 using the Simplify D-dimer
test, respectively. Efficiency is considerably lower when
using those cut-off values: the number of patients that
need referral is 76.2% and 87.6% respectively, as com-
pared to 65% with the Wells cut-off value of ≤ 4i nt h e
Christopher-study.
Several aspects of this analysis require comment.
Firstly, we based the analysis on the test characteristics
of two qualitative POC-D-dimer tests as reported in a
diagnostic meta-analysis. In this meta-analysis most of
the studies included patients suspected of DVT. Only
six studies included patients with PE. However in a cov-
ariate analysis of studies with only DVT both the sensi-
tivity and the specificity of the SimpliRed and the
Simplify D-dimer test were essentially the same as in
the overall analysis.
Secondly, several studies performed in secondary care
(PE-prevalence ranging from 3.8-10%) show that a strat-
egy using a CDR and a qualitative POC- D-dimer test
can be used safely to exclude PE. Moreover these studies
show a good efficiency ranging from 44-66% [7,10-13].
Wells et al were the first to show that the combination of
Wells CDR <2 and a negative D-dimer test was safe to
exclude PE. (prevalence 9.5%, failure rate 0.2%, efficiency
47%) [7]. According to Hogg and co-workers the Simplify
D-dimer test alone was not sufficiently sensitive (sensitiv-
ity 81.8%, specificity 74.2%) to exclude PE in low-risk
patients (prevalence PE 5.3%) presenting to the emer-
gency department (ED) with pleuritic chest pain. How-
ever, when the Simplify D-dimer test was combined with
a low-clinical probability Wells-rule the negative predic-
tive value of the combined test was 99.3% (CI 97.4-
99.9%): high enough to exclude PE safely [10]. Kline et al
showed in low-risk ED-patients (prevalence PE 4.7%) that
combination of a physician’su n s t r u c t u r e de s t i m a t eo f
pre-test probability of PE of <15% and a negative
Simplify-D-dimer test excluded PE safely (sensitivity
D-Dimer-test 80.6%, specificity 72.5%) [11]. In a primary
care based management study sensitivity of the Simplify
D-dimer test proved to be sufficient to exclude deep vein
thrombosis (DVT) safely in patients with a low clinical
probability. The relatively higher specificity, as compared
to laboratory based quantitative D-dimer tests provided a
good efficiency [14].
Table 2 Results of failure-rate and efficiency in 2 scenarios at different cut-off values of the Wells-rule in comparison
with results of the Christopher-study
Wells N= Prevalence PE SimpliRed:
Sens 85%
Spec 74%
Simplify:
Sens 87%
Spec 62%
Christopher 2006 Tinaquant/Vidas
Failure-rate (95% CI) Efficiency Failure-rate (95% CI) Efficiency Failure-rate (95% CI) Efficiency
≤ 4 1876 12.0% (226/1876) 2.7% (1.9-3.8%) 46.5% 2.8% (1.9-3.9%) 38.9% 0.5% (0.2-1.2%) 35.0%
≤ 3 1772 11.3% (201/1772) 2.5% (1.7-3.6%) 44.2% 2.6% (1.7-3.8%) 37.0% 0.4% (0.1-1.1%) 34.1%
≤ 2 919 6.3% (58/919) 1.4% (0.6-2.6%) 23.9% 1.5% (0.6-2.9%) 20.1% 0.2% (0.0-1.0%) 19.8%
<2 915 6.3% (58/915) 1.4%(0.6-2.6%) 23.8% 1.5% (0.6-2.9%) 20.0% 0.2%(0.0-1.0%) 19.8%
≤ 1 611 4.6% (28/611) 0.9% (0.3-2.3%) 16.1% 1.1% (0.3-2.8%) 13.5% 0.0% (0.0-1.0%) 14.5%
0 559 4.3% (24/559) 1.0% (0.3-2.6%) 14.8% 0.9% (0.2-2.6%) 12.4% 0.0% (0.0-1.0%) 13.8%
N = Number of outpatients in different Wells clinical probability groups
CI = Confidence interval
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the studies of Hogg and Kline was only 81.8% and 80.6%,
respectively, the negative predictive value of the combined
strategy using a pre-test probability assessment and the
Simplify D-Dimer test was high enough to exclude PE
safely due to the low PE-prevalence in these studies.
Thirdly, a weak point of the analysis is that although we
have excluded all in-patients the study-population is still
not really a primary care population. The outpatients
included in the Christopher-study are likely selectively
biased as the primary care physician used his own judge-
ment before referring the patient. In the Christopher-study
the PE-prevalence was 20.2%. In daily practice when a pri-
mary care physician will use the Wells-CDR rule combined
with a POC D-dimer test the prevalence of PE in suspected
patients is expected to be lower which will improve the
negative predictive value (and thereby safety and efficiency)
of an exclusion strategy for PE in primary care.
Fourthly, we don’t know how well the Wells CDR
would perform in primary care. In secondary care the
Wells rule is usually applied after routine blood tests,
chest radiography and electrocardiography. The primary
care physician is usually lacking this information and
this will clearly influence the scoring of the subjective
variable ‘pulmonary embolism is as likely as or more
likely than an alternative diagnosis’.
Fifthly, we know that the test characteristics of the
POC-D-dimer test, unlike this scenario, are not fixed
but are influenced by the prevalence of PE in the differ-
ent Wells-groups. It is likely that the specificity of the
D-dimer test will increase as the prevalence decreases.
This might improve the negative predictive value of the
strategy in primary care [17,18].
Sixthly, in this analysis the SimpliRED D-dimer assay
was used which has certain limitations. It is known that
this method may be associated with a risk for inade-
quate interpretation due to the fact that the results are
based on a subjective interpretation of the presence or
absence of agglutination [19]. This risk for inadequate
interpretation will be enhanced by infrequent use of the
assay. An average Dutch primary care physician will use
a POC D-dimer assay for exclusion of PE only 3-5 times
a year. However the physician will use the same assay
also for exclusion of DVT [14]. We expect the Dutch
primary care physician to apply the POC D-dimer test
12-15 times a year in both suspected PE-patients as
DVT-patients. We think this will justify an adequate
and reliable use of the assay.
Finally, although in scenario 2 (Simplify) the point
estimate failure rate in Wells CDR < 2 is within the
safety limits, the upper confidence limit exceeds 2.7%.
Confidence intervals become larger with decreasing
Figure 1 Failure rate versus efficiency in 2 scenarios at different cut-off values of the Wells CDR in comparison with results from the
Christopher-study.
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increasing number of patients the proportion in the
lower Wells-CDR score will be higher and the confi-
dence interval will become narrower. Therefore scenario
2 might also be safe in Wells <2.
In secondary care, in a strategy using a more sensitive,
quantitative D-dimer test, a cut-off value of Wells ≤ 4i s
generally accepted as safe. Although the sensitivity of
the POC qualitative D-dimer test is lower, the specificity
of the test is higher and as a consequence efficiency is
higher at the cost of safety. Recalibration of the Wells-
rule for a primary care situation might overcome the
safety problems.
Conclusion
In this scenario-analysis we could exclude PE safely with
a diagnostic strategy using the Wells CDR and a qualita-
tive D-dimer test, albeit with only a moderate efficiency.
A prospective study is needed to assess safety and effi-
ciency of this strategy in a true primary care population.
Recalibration of the Wells-rule or adaption of cut-off
values might then be needed.
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